Dsm

DSM acquires HMO firm Glycom in €765m deal

25-Feb-2020 By Will Chu

Royal DSM has reached agreement to acquire Danish Human Milk Oligosaccharide (HMO) supplier Glycom in a deal worth €765m.

‘Setting new standards’ DSM China extends summer shut down at vitamin C site for additional upgrades

18-Jul-2019 By Guan Yu Lim

DSM will extend the annual summer shut down period at its Jiangshan vitamin C site in China so further upgrades to the facility can be carried out.

NEWS IN BRIEF

DSM benefits from temporary vitamin price effect while raising 2018 outlook

09-May-2018 By Mary Ellen Shoup

DSM reported above market volume and sales gains for Q1 2018 with strong performance in its underlying nutrition business, which grew 5% in volume compared to the same period last year driven by strong sales in its i-Health and vitamin pre-mix businesses....

DSM finishes sale of pharma assets to US firm

30-Aug-2017 By Hank Schultz

DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.

'We've made big pills a thing of the past.'

Big investment, small pills: DSM invests €27m in omega-3 technology

12-Oct-2016 By Annie Harrison-Dunn

DSM has invested over €27 million in its ‘3C technology’ which concentrates DHA and EPA up to 85% and helps reduce capsule size by up to three times.

NCN says 'curated' list helps boost success of innovation events

29-Aug-2016 By Hank Schultz

Nutrition Capital Network partner Grant Ferrier said the mentoring program his company provides has boosted the success of innovation partnership programs such as the one sponsored by DSM.

DSM stays in leader zone of Dow Jones sustainability index

23-Sep-2015 By Eliot Beer

DSM has been named as one of its sector’s leaders in environmental prudence in the Dow Jones Sustainability World Index, but the company says it sees such lists as a means, not an end.

DSM debuts enzyme ingredient designed to break down residual gluten

22-Jul-2015 By Hank Schultz

Consumers who are seeking to limit their exposure to gluten have another line of defense in a new product released by DSM. Called Tolerase G, the enzyme can serve to break down residual gluten in a meal before it can cause a reaction, the company said.

DSM backs natural zeaxanthin with exclusive deal

01-Oct-2014 By Shane STARLING

DSM, previously focused on synthetic zeaxanthin, has launched a natural version sourced from longtime carotenoid partner Kemin.

DSM to increase omega-3s capacity in light of dietary reference intake review

28-Aug-2014 By Hank Schultz

The move by Canadian and US health authorities to look at the establishment of a dietary reference intake for omega-3s will be a boon both for public health and the health of the market for these important nutrients, omega-3s supplier DSM says.  The company...

DSM flexing its acquisition muscles at IFT

10-Jun-2014 By Hank Schultz

DSM will highlight all the recent additions to its royal crest at IFT. The multinational food, beverage and supplement ingredient supplier will in particular be featuring its life’s DHA ingredient at the Institute of Food Technologists show in New Orleans...

Dispatches from Vitafoods Europe 2014

Omega-3’s newest big fish reveals sector ambitions

15-May-2014 By Shane STARLING

Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through...

Natural astaxanthin group’s questioning of synthetic astaxanthin quality met with strong DSM defense

11-Apr-2014 By Stephen Daniells and Shane Starling

The Natural Algae Astaxanthin Association (NAXA) has again questioned the quality and regulatory status of DSM’s synthetic astaxanthin ingredient, with new data reportedly showing ‘vastly inferior antioxidant potential’ compared with the natural, algae-derived...

DSM holds first-ever call for innovation partners

03-Apr-2014 By Maggie Hennessy

In an effort to jumpstart growth in new product development, ingredients giant DSM is hosting its inaugural Innovation Partnering Conference at its Parsippany, NJ, headquarters in June.

DSM profits rise 27% but nutrition space ‘sluggish’ as omega-3 bites

05-Nov-2013 By Shane STARLING

DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.